Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-16

Clinical Trial Update: Effect of Vericiguat on cardiAc Remodeling in Patients With Heart faiLure and Reduced Ejection fractioN (HFrEF): A Prospective sTudy usIng NOvel Echocardiographic Imaging Techniques (VALENTINO)

View source ↗

Summary

This completed clinical trial evaluates the effect of vericiguat on cardiac remodeling in patients with heart failure with reduced ejection fraction. It uses no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verquvo (vericiguat)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: HFrEF - Heart Failure With Reduced Ejection Fraction | Status: COMPLETED